Pilonidal Disease
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Integra LifeSciencesAustralia - Clayton
2 programsNovel Wound Healing ProtocolN/A1 trial
Wound Sheet Matrix 2-Layer and Powder Urinary Bladder MatrixN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Integra LifeSciencesWound Sheet Matrix 2-Layer and Powder Urinary Bladder Matrix
Integra LifeSciencesNovel Wound Healing Protocol
Clinical Trials (2)
Total enrollment: 22 patients across 2 trials
The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series
Start: Mar 2019Est. completion: Nov 20192 patients
N/ATerminated
Feasibility of a Novel Technique for Pilonidal Wound Healing
Start: Feb 2015Est. completion: Jul 201620 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.